Longeveron Inc. (LGVN) Q1 2023 Earnings Call Transcript

Longeveron Inc. (NASDAQ:LGVN) Q1 2023 Earnings Convention Name Could 12, 2023 8:30 AM ET

Firm Individuals

James Clavijo – Chief Monetary Officer

Wa’el Hashad – Chief Govt Officer

Chris Min – Appearing Chief Medical Officer & Guide

Convention Name Individuals

Michael Okunewitch – Maxim Group


Good morning, and welcome to Longeveron’s name right now to debate the corporate’s 2023 First Quarter and Monetary Outcomes. All individuals are at present in listen-only mode. Following the formal presentation, we’ll open the decision up for a question-and-answer session.

I might now like to show the convention over to James Clavijo, Chief Monetary Officer of Longeveron. James, you might now proceed.

James Clavijo

Thanks, operator. Good morning, everybody, and welcome to Longeveron’s first quarter 2023 Name. As we speak, we’ll present a enterprise replace and talk about monetary outcomes for the primary quarter of 2023. Earlier this morning, we issued a press launch with these outcomes, which may be discovered underneath the Traders part of our web site at www.longeveron.com.

I’m joined on the decision right now by the next members of Longeveron’s administration workforce; Mr. Wa’el Hashad, Chief Govt Officer; Dr. Joshua Hare, Co-Founder, Chief Scientific Officer and Chairman; and Dr. Chris Min, Appearing Chief Medical Officer and Guide to Longeveron. Mr. Hashad will start with a short assertion and company overview, then Dr. Min will present a assessment of updates from Longeveron’s medical applications in Hypoplastic Left Coronary heart Syndrome or HLHS, Alzheimer’s illness and aging-related frailty, after which I’ll assessment our 2023 first quarter monetary outcomes. Final, we’ll open the decision for Q&A

As a reminder, throughout this name, we can be making forward-looking statements, that are topic to numerous dangers and uncertainties that might trigger our precise outcomes to vary materially from these statements. Any such statements ought to be thought of along side cautionary statements

Back To Top